AzTrials
AzTrials

Pain, PostoperativeCHIRTAPNCT04108221

Study Comparing Two Methods of TransversusAbdominis Plane

A study testing laparoscopy or laparotomy withTransversusAbdominis Plane Block in people with Pain, Postoperative, run by Institut Jean-Godinot at 1 site in France.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

Interventional, randomised, prospective, multicentric study Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pain, Postoperative
What is being tested?
laparoscopy or laparotomy withTransversusAbdominis Plane Block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteFrance
Study dates
16 Sep 2019to 31 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient over 18 years old
  • Patient undergoing laparoscopic or laparotomic abdominal surgery at the investigator hospital.
  • Patient mastering the French language
  • Patient who received informed information about the study and signed a consent
  • Patient affiliated to a social security scheme.

Who cannot join

  • Patients with chronic pain
  • Patients with opioid dependence
  • Patients allergic to local anesthetic
  • Patient who has not signed the consent of the study.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Institut Godinot

    Reims, 51726

Other trials in France

About this study

Official title: Randomised Study of Noninferiority Comparing a TransversusAbdominis Plane Block Surgical (c-TAP Block) to the Ultrasound-guided Abdominis Plane Block Transversus (Us-TAP Block) in Postoperative Analgesia After Laparoscopy or Laparotomy

Interventional, randomised, prospective, multicentric study

Read the detailed description

Interventional, randomised, prospective, multicentric and single blind study

Primary objective :

demonstrate the equivalence of c-TAP Block to us-TAP Block in postoperative analgesia

Secondary objective :

  • Assess the effectiveness of c-TAP block on us-TAP Block in the obese and/or malnourished patient subgroup
  • Compare the running time of the c-TAP Block to the us-TAP Block
  • Assess the safety of the c-TAP Block gesture in terms of trauma to the intraperitoneal organs by the injection needle two groups:
  • Arm A : c-TAP Block performed by the surgeon
  • Arm B : us-TAP Block performed by the anesthesist under ultrasound control

Schedule :

  • Inclusions start at: 16/09/2019
  • End date of inclusions: 31/03/2022
  • End date of follow-up: 01/04/2022
  • Study report: 30/09/2022
Being tested
laparoscopy or laparotomy withTransversusAbdominis Plane Block
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • laparoscopy or laparotomy withTransversusAbdominis Plane BlockProcedure or surgery

    The US-TAP is performed by the anesthetist under ultrasound control after the end of the procedure of laparoscopy or laparotomy. Under sterile conditions, the anesthetist identifies the oblique abdominal muscles externally, obliquely internally and transversely by ultrasound. A 20 ml needle of 0.5% ropivacaine is injected.

    The surgical TAP (c-TAP) block is performed by the surgeon at the end of the procedure of laparoscopy or laparotomy.The needle and the product used are identical to those of the us-TAP block. The positioning of the needle is in the plane of the fascia between the internal oblique muscle and the transverse muscle, identified by a significant loss of resistance.

Study groups in NCT04108221
Study groupRoleWhat they receive
Arm A : c-TAP Block performed by surgeonExperimentalc-TAP Block Block performed by surgeon
Receives: Procedure: laparoscopy or laparotomy withTransversusAbdominis Plane Block
Arm B : us-TAP Block performed by anesthetistActive comparatorus-TAP Block by anesthetist
Receives: Procedure: laparoscopy or laparotomy withTransversusAbdominis Plane Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evolution pain intensity scores, assessed by the numerical pain scale (EN), postoperative and need for systemic analgesics (intravenously or by mouth) during the 24 hours following the end of the procedure

    Evolution pain intensity scores, assessed by the numerical pain scale (EN 1 up to 10)

    Measured: 24 hours

Secondary outcomes (3)
  1. Failure rate in the obese and / or malnourished patient subgroup

    The failure will be defined as follows: a pain evaluated at> 4/10 on EN that requires intravenous or systemic analgesia

    Measured: 24 hours

  2. Time in minutes of each of the TAP Block techniques

    The time will be quantified with a stopwatch. For the c-TAP, the stopwatch will be started as soon as the injection equipment of the locoregional anesthesia is received. For the us-TAP block, the stopwatch will be started after the end of the surgical procedure and as soon as the anesthetist starts to wash his hands to proceed with the injection

    Measured: 24 hours

  3. Occurrence of trauma to the intra-abdominal organs caused by the injection needle

    number of traumas that have occurred

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Sep 2019
  2. Study start16 Sep 2019
  3. Primary completion31 Mar 2022 (estimated)
  4. Study completion31 Mar 2022 (estimated)

Why it stopped: Principal Investigator condition

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
two arms : arm A : c-TAP Block performed by surgeon arm B : us-TAP Block performed by anesthetist
Masking
Single blind
Who is masked
Investigator
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04108221
Sponsor's protocol ID
2019-A01444-53
Acronym
CHIRTAP
Status last verified
Jun 2021
First submitted
26 Sep 2019
Last updated
7 Apr 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing laparoscopy or laparotomy withTransversusAbdominis Plane Block in people with Pain, Postoperative, run by Institut Jean-Godinot at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 7 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evolution pain intensity scores, assessed by the numerical pain scale (EN), postoperative and need for systemic analgesics (intravenously or by mouth) during the 24 hours following the end of the procedure (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in